IBL Tool - Digital Library

Digital Library

Journal description

All volumes of the corresponding journal

All issues of the corresponding volume

All articles of the corresponding issues

102 results found

no	title	author	magazine	year	volume	issue	page(s)	type
1	Author index			2003	41	S3	p. S121-S122 2 p.	article
2	E-41. A clinicopathological study of resected adenocarcinoma less than 2 cm in size	Ikeda, Norihiko		2003	41	S3	p. S51- 1 p.	article
3	E-23. A DNA methylation profile of lung cancer	Esteller, Manel		2003	41	S3	p. S30- 1 p.	article
4	E-54. Alternative therapy plus conventional therapy: The science behind art or the art behind science	Mok, Tony S.K.		2003	41	S3	p. S69- 1 p.	article
5	E-68. Are new cytotoxic agents worth investigating?	Scagliotti, Giorgio V.		2003	41	S3	p. S84-S85 2 p.	article
6	E-61. Assessment and management of fatigue in lung cancer	Pirker, Robert		2003	41	S3	p. S77- 1 p.	article
7	E-64. Bcl-2 as a target in lung cancer	Rudin, Charles M.		2003	41	S3	p. S80- 1 p.	article
8	E-1.Cancer management & clinical research in developing countries	Abratt, Raymond P.		2003	41	S3	p. S3-S4 2 p.	article
9	E-40. Chemoprevention of lung cancer: Challenges in the 21st century. Genetics, risk modeling, and molecular targets	Hong, Waun Ki		2003	41	S3	p. S50- 1 p.	article
10	E-10. Chemoradiation for stage III non-small cell lung cancer	Bonomi, Philip		2003	41	S3	p. S14- 1 p.	article
11	E-55. Chemoradiation of stage III NSCLC	Mornex, Francoise		2003	41	S3	p. S70- 1 p.	article
12	E-20. Chemotherapy for advanced NSCLC in PS2 patients	Cullen, Michael		2003	41	S3	p. S27- 1 p.	article
13	E-34. Chemotherapy for non-small cell lung cancer in the elderly	Gridelli, Cesare		2003	41	S3	p. S43-S44 2 p.	article
14	E-66. Clinical experience with Tarceva™	Sandier, Alan B.		2003	41	S3	p. S82- 1 p.	article
15	E-47. Combined modality therapy in older patients with stage III NSCLC and limited SCLC	Langer, Corey J.		2003	41	S3	p. S57-S60 4 p.	article
16	E-88. Combined modality therapy of limited stage SCLC	Wagner, Henry		2003	41	S3	p. S107- 1 p.	article
17	E-21. Cyclooxygenase-2-dependent regulation of the malignant phenotype in non-small cell lung cancer	Dubinett, Steven M.		2003	41	S3	p. S28- 1 p.	article
18	E-87.Early detection and chemoprevention of lung cancer	Zandwijk, Nico van		2003	41	S3	p. S106- 1 p.	article
19	E-25. Effective treatments for smoking: Established and experimental approaches	Fagerstrom, Karl		2003	41	S3	p. S32- 1 p.	article
20	E-5. Encouraging informed patients: Towards joint decision making	Baird, Jesme		2003	41	S3	p. S8- 1 p.	article
21	E-80.Enhancing communication in the lung cancer consultation	Tattersall, Martin		2003	41	S3	p. S99- 1 p.	article
22	E-67. Epidemiology and molecular epidemiology of lung cancer in men and women	Santella, Regina M.		2003	41	S3	p. S83- 1 p.	article
23	E-29. Epidermal growth factor receptor tyrosine kinase inhibitors: Single agent therapy	Fukuoka, Masahiro		2003	41	S3	p. S38- 1 p.	article
24	E-8. Evidence-based palliative radiotherapy	Bezjak, Andrea		2003	41	S3	p. S12- 1 p.	article
25	E-32. Global tobacco policy	Gray, Nigel		2003	41	S3	p. S41- 1 p.	article
26	E-53. Helical tomotherapy: An innovative technological radiation therapeutic approach for lung cancer	Mehta, Minesh		2003	41	S3	p. S67-S68 2 p.	article
27	E-82. High-grade neuroendocrine (NE) tumors: What we know and important unanswered questions	Travis, William D.		2003	41	S3	p. S101- 1 p.	article
28	E-38. Historical milestones in small cell lung cancer	Hansen, Heine H.		2003	41	S3	p. S48- 1 p.	article
29	E-73.Hormones - do they make a difference in lung cancer?	Siegfried, Jill M.		2003	41	S3	p. S91- 1 p.	article
30	E-76.Identifying the high risk subject: Assessment of DNA damage and repair	Spitz, Margaret R.		2003	41	S3	p. S95- 1 p.	article
31	E-15. Imaging hypoxic micro-regions of lung cancers	Chapman, J.D.		2003	41	S3	p. S21-S22 2 p.	article
32	E-9. Improving lung cancer outcomes: Patient perspective	Blum, Diane		2003	41	S3	p. S13- 1 p.	article
33	E-59. Improving lung cancer outcomes: Physician perspective	Peters, Matthew		2003	41	S3	p. S75- 1 p.	article
34	E-17. Improving the therapeutic index of radiosensitizers	Choy, Hak		2003	41	S3	p. S24- 1 p.	article
35	E-69. Influential papers since the last IASLC Conference: Cytotoxic therapy	Schiller, Joan H.		2003	41	S3	p. S86-S87 2 p.	article
36	E-2. Inhibitors of MAP kinases	Adjei, Alex A.		2003	41	S3	p. S5- 1 p.	article
37	E-7. Inluential radiotherapy papers published since the last IASLC conference	Ball, David		2003	41	S3	p. S10-S11 2 p.	article
38	E-37. Integrated genomic and proteomics-based approaches to lung cancer profiling	Hanash, Sam		2003	41	S3	p. S47- 1 p.	article
39	E-48. Is adjuvant chemotherapy a part of the curative treatment of operable non-small cell lung cancer?	Le Chevalier, Thierry		2003	41	S3	p. S61- 1 p.	article
40	E-86.Is there still a role for mediastinoscopy?	Urschel, John		2003	41	S3	p. S105- 1 p.	article
41	E-36. Long-term results after vertebral body resections for non-small cell lung cancer	Grunenwald, Dominique H.		2003	41	S3	p. S46- 1 p.	article
42	E-84.Long-term results of surgical intervention of T4 tumors: left atrium and/or great vessels	Tsuchiya, Ryosuke		2003	41	S3	p. S103- 1 p.	article
43	E-91. Long-term results of surgical intervention of T4 tumors resection of carcinomatous pleural disease	Yokoi, Kohei		2003	41	S3	p. S110- 1 p.	article
44	E-19. Lung cancer clinical trials: Principles and pitfalls	Crowley, John J.		2003	41	S3	p. S26- 1 p.	article
45	E-6. Lung cancer in the older person	Balducci, Lordovico		2003	41	S3	p. S9- 1 p.	article
46	E-16. Molecular and cytogenetic alterations in Chinese non-small cell lung cancer	Cheng, Shujun		2003	41	S3	p. S23- 1 p.	article
47	E-26. Molecular markers in early detection	Field, John K.		2003	41	S3	p. S33-S34 2 p.	article
48	E-12. Molecular pathology of neuroendocrine lung tumors	Brambilla, Elisabeth		2003	41	S3	p. S16-S17 2 p.	article
49	E-90. Molecular pathology of small cell lung cancer	Wistuba, Ignacio I.		2003	41	S3	p. S109- 1 p.	article
50	E-60. Molecular profiling of non-small cell lung cancer	Petersen, Iver		2003	41	S3	p. S76- 1 p.	article
51	E-79.Molecular targets for prevention of lung cancer	Szabo, Eva		2003	41	S3	p. S98- 1 p.	article
52	E-43. Most influential papers in surgery	Johnston, Michael R.		2003	41	S3	p. S53- 1 p.	article
53	E-56. Multimodality approaches for malignant pleural mesothelioma	Pass, Harvey I.		2003	41	S3	p. S71- 1 p.	article
54	E-65. Neuroendocrine tumors of the lung	Salgia, Ravi		2003	41	S3	p. S81- 1 p.	article
55	E-78.New bronchoscopic interventions	Sutedja, Tom G.		2003	41	S3	p. S97- 1 p.	article
56	E-63. New gene targets for lung cancer therapy	Roth, Jack A.		2003	41	S3	p. S79- 1 p.	article
57	E-75.Optimal number of cytotoxic agents and chemotherapy cycles for advanced NSCLC	Socinski, Mark A.		2003	41	S3	p. S93-S94 2 p.	article
58	E-83. Outpatient management of malignant pleural effusions	Tremblay, Alain		2003	41	S3	p. S102- 1 p.	article
59	E-27. Overview: Impact of microarray technology on lung cancer classification and biomarker development	Franklin, Wilbur A.		2003	41	S3	p. S35-S36 2 p.	article
60	E-11. PET scanning for operable non-small cell lung cancer	Boyer, Michael J.		2003	41	S3	p. S15- 1 p.	article
61	E-62. Pharmacogenomics: Individualized therapy	Rosell, Rafael		2003	41	S3	p. S78- 1 p.	article
62	E-46. Phase II trials of promising chemopreventive agents	Lam, Stephen		2003	41	S3	p. S56- 1 p.	article
63	E-28. Placing lung cancer on the global health care agenda: The global lung cancer coalition	Freiheit, Deirdre		2003	41	S3	p. S37- 1 p.	article
64	E-3. Politicizing lung cancer: Mobilizing decision makers' support	Aldige, Carolyn		2003	41	S3	p. S6- 1 p.	article
65	E-85.Positron emission tomography (PET) and CT co-registration: incorporating functional and anatomical information in radiation treatment planning for lung cancer	Ung, Yee C.		2003	41	S3	p. S104- 1 p.	article
66	E-24. Practice guidelines: Do they matter? Do they work?	Evans, William K.		2003	41	S3	p. S31- 1 p.	article
67	E-89. Pre-operative chemotherapy for stage I to III NSCLC	Westeel, Virginie		2003	41	S3	p. S108- 1 p.	article
68	E-33. Prevention and management of brain metatsases	Gregor, Anna		2003	41	S3	p. S42- 1 p.	article
69	E-18. Problems in the pathologic diagnosis of malignant mesothelioma	Churg, Andrew		2003	41	S3	p. S25- 1 p.	article
70	E-74. Pulmonary neuroendocrine tumors: Incidence and prognosis of histological subtypes. A population-based study in Denmark	Skuladottir, Halla		2003	41	S3	p. S92- 1 p.	article
71	E-71.Radiation oncology research priorities in the management of small cell lung cancer	Sheehan, Finbarr		2003	41	S3	p. S89- 1 p.	article
72	E-4. Radiation therapy of lung cancer detected by screening	Armstrong, John G.		2003	41	S3	p. S7- 1 p.	article
73	E-50. Radiofrequency ablation	Luketich, James D.		2003	41	S3	p. S63- 1 p.	article
74	E-52. Role of PET in assessing response to radical chemoradiation	Mac Manus, Michael P.		2003	41	S3	p. S65-S66 2 p.	article
75	E-42. Screening and early detection of lung cancer	Jett, James R.		2003	41	S3	p. S52- 1 p.	article
76	E-58. Screening for lung cancer	Patz Jr., Edward F.		2003	41	S3	p. S73-S74 2 p.	article
77	E-22. Should surgery (S) be reconsidered for limited small-cell lung cancer (LD-SCLC)?	Eberhardt, Wilfried		2003	41	S3	p. S29- 1 p.	article
78	E-45. Small cell lung cancer: Targeting minimal residual disease	Krug, Lee M.		2003	41	S3	p. S55- 1 p.	article
79	E-81.Small cell lung cancer- treatment strategies in the elderly and poor performance status patients	Thatcher, N.		2003	41	S3	p. S100- 1 p.	article
80	E-35. Smoking and the sexes	Gritz, Ellen R.		2003	41	S3	p. S45- 1 p.	article
81	E-39. Standardization of biomarkers for chemoprevention studies in lung cancer	Hirsch, Fred R.		2003	41	S3	p. S49- 1 p.	article
82	E-72.Statistical strategies for analyzing the microarray data in human lung cancer	Shyr, Yu		2003	41	S3	p. S90- 1 p.	article
83	E-57. Surgical approach to neuroendocrine tumors	Passlick, Berward		2003	41	S3	p. S72- 1 p.	article
84	E-44. Systemic therapy for mesothelioma: Old and new	Kindler, Hedy Lee		2003	41	S3	p. S54- 1 p.	article
85	E-70. Telomerase in lung cancer	Shay, J.W.		2003	41	S3	p. S88- 1 p.	article
86	E-30. The hallmarks of lung cancer	Gazdar, Adi F.		2003	41	S3	p. S39- 1 p.	article
87	E-31. The IASLC staging revision project	Goldstraw, Peter		2003	41	S3	p. S40- 1 p.	article
88	E-77.The need for a world strategy for clinical trials	Stephens, Richard		2003	41	S3	p. S96- 1 p.	article
89	E-13. The risks of modern cigarettes	Burns, David M.		2003	41	S3	p. S18-S19 2 p.	article
90	E-51. The work of the cochrane collaboration lung cancer review group	Macbeth, Fergus		2003	41	S3	p. S64- 1 p.	article
91	E-49. Treatment of cancer anorexia/cachexia	Loprinzi, Charles L.		2003	41	S3	p. S62- 1 p.	article
92	E-14. Tumor proteomic patterns predict classification and tumor behavior in human non-small cell lung cancer	Yanagisawa, Kiyoshi		2003	41	S3	p. S20- 1 p.	article
93	I-99. A phase II efficacy study of brostallicin, a novel minor groove binder (MGB), in patients with platinum refractory or resistant non-small cell lung cancer (NSCLC)	Sandler, A.		2003	41	S3	p. S118- 1 p.	article
94	I-100. Candidate predictive and surrogate markers of antitumor activity with Tarceva™	Soulières, Denis		2003	41	S3	p. S119- 1 p.	article
95	I-97. Clinical benefit in NSCLC: The evidence for Gefitinib (“Iressa”)	Lynch, Thomas		2003	41	S3	p. S116- 1 p.	article
96	I-93. Gefitinib (“Iressa”): The patients' experience	Goss, Glen		2003	41	S3	p. S112- 1 p.	article
97	I-101. Novel approaches in oncology	Wheeler, Catherine		2003	41	S3	p. S120- 1 p.	article
98	I-94. Symptoms and quality of life: Important patient outcomes?	Harper, Peter		2003	41	S3	p. S113- 1 p.	article
99	I-96. Tarceva™: A potent HER1/EGFR-tyrosine kinase inhibitor	Hidalgo, Manuel		2003	41	S3	p. S115- 1 p.	article
100	I-98. Tarceva™-associated rash to maximize treatment outcome?	Pérez-Soler, Romàn		2003	41	S3	p. S117- 1 p.	article
101	I-92. Targeting HER1/EGFR to improve outcomes for patients with NSCLC	Gatzemeier, Ulrich		2003	41	S3	p. S111- 1 p.	article
102	I-95. Targeting the EGFR: Prognostic and clinical implications	Herbst, Roy S.		2003	41	S3	p. S114- 1 p.	article

102 results found

Koninklijke Bibliotheek - National Library of the Netherlands